Home >  Registry
     
 
 Protocol Registry Trial Results IFPMA Background Links
About this Registry

This registry serves as a global repository for information on ongoing Roche Pharmaceuticals Phase II to Phase IV clinical studies, Phase I studies in patients and Roche Diagnostics interventional studies on advanced diagnostic products.

For More Information 

Common Questions
More Frequently Asked Questions 
Overview of Clinical Trials 
Glossary of Terms 
Phase Definitions 
Field Definitions 
Roche Clinical Trial Global Policy 
Site Provided by Thomson CenterWatch

Non-Hodgkin's Lymphoma

  • A Study of MabThera (Rituximab) as Maintenance Therapy in Patients With Aggressive Non-Hodgkin's Lymphoma
    Recruiting


  • A Dose-Escalating Study of R7159 Monotherapy in Patients With CD20+ Malignant Disease.
    Recruiting


  • MAXIMA Study: A Study of Maintenance Therapy With MabThera (Rituximab) in Patients With Non-Hodgkin's Lymphoma.
    No longer recruiting


  • A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas
    No longer recruiting


  • A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)
    No longer recruiting


  • A Study of Ocrelizumab in Patients With Follicular Non-Hodgkin's Lymphoma (NHL)
    No longer recruiting


  • A Study of MabThera (Rituximab) in Patients With Advanced Non-Hodgkin's Lymphoma
    No longer recruiting


  • A Study of MabThera (Rituximab) in Patients With HIV-Related Non-Hodgkin's Lymphoma
    Completed


  • A Study of MabThera (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's Lymphoma
    Completed


  • A Study of MabThera (Rituximab) in Patients With Relapsed Centroblastic Centrocytic Non-Hodgkin's Lymphoma
    Completed


  • An Expanded Access Program of Neulastim (Pegfilgrastim)in Patients With Non-Hodgkin's Lymphoma
    Completed


  • A Study of MabThera (Rituximab) in Combination With a Standard Chemotherapy Regimen in Patients With Diffuse Large B-Cell Non-Hodgkin's Lymphoma
    Completed


    		•

    © 1996-2008 F.Hoffmann-La Roche Ltd See our legal Statement